EU Gives $88 Million to CureVac to Ramp Up COVID-19 Vaccine
EU Gives $88 Million to CureVac to Ramp Up COVID-19 Vaccine
GALWAY, IRELAND--April 1, 2020--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--The European Union (EU) has offered up to 80 million euro ($88 million) to German vaccine developer CureVac to scale up development and production of a vaccine against the Coronavirus in Europe.
Within this article: Details investment, proposed vaccine, controversy over alleged U.S. offer, related Coronavirus R&D and alliances
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- U.S. Supplement Production Brings Millions in Spending
- Samsung Biologics Constructing ADC Plant in South Korea
- Data Center Activity Propels Virginia to $12.7 Billion of Projects Under Co...
- Pharma Company Zoetis Signs PPA with Scout Clean Energy to Support Growing ...
- China's Rongsheng Petrochemical Ups Role in Polyester Chips